David R. Drosick
Hematology Oncology | Oncology
601 Ivy Gateway
Suite 1100
Cincinnati, OH 45245
Suite 1100
Cincinnati, OH 45245
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Sustainable Integration of US Food and Drug Administration-Approved Biosimilars: Pharmacy- Versus Physician-Driven Change.
Journal: JCO oncology practice
Published: September 22, 2023
Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice.
Journal: JCO oncology practice
Published: June 27, 2023
Closing the Testing Gap: Standardization of Comprehensive Biomarker Testing for Metastatic Non-Small-Cell Lung Cancer in a Large Community Oncology Practice.
Journal: JCO oncology practice
Published: May 01, 2023
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 02, 2017
Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial.
Journal: Clinical breast cancer
Published: September 23, 2015
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.
Journal: Breast cancer research and treatment
Published: July 09, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026